Metformin
Oligoovulation
59th Medical WingSmall moleculePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 49/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Oligoovulation cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Msj-0011 Merck KGaA, Darmstadt, Germany | Phase 3 | BB |
Hcg Merck KGaA, Darmstadt, Germany | Phase 3 | BB |
CLOMIPHENE CITRATE 59th Medical Wing | Phase 3 | BB |
Follitropin Alpha Merck KGaA, Darmstadt, Germany | Phase 3 | BB |
Same molecule, other indications
Metformin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →